Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide—A phase II study

This publication has 26 references indexed in Scilit:

• A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
  Published by Elsevier ,2000
• Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan
  Cancer, 1996
• Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
  European Journal Of Cancer, 1995
• Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer
  Annals of Oncology, 1994
• Carboplatin and Etoposide in Extensive Small Cell Lung Cancer
  Acta Oncologica, 1994
• Phase I/II Trial of Etoposide and Carboplatin in Extensive Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1993
• Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.
  Journal of Clinical Oncology, 1992
• Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1991
• A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer
  Lung Cancer, 1990
• Alkylating agents in bronchogenic carcinoma
  The American Journal of Medicine, 1969